-
Chemours (CC) PT Lowered to $14 at Citi
-
Pre-Open Movers 07/12: (HOOK) (MCRN) (SFIX) (SNAP) (USX) (EMKR) (ILMN) (HI) (CC)
-
Citi Downgrades Chemours (CC) to Neutral
-
Chemours (CC) PT Lowered to $40 at Citi
-
Chemours (CC) PT Raised to $43 at Citi
-
Citi Upgrades Chemours (CC) to Buy
-
Citi Downgrades Chemours (CC) to Neutral
-
Chemours (CC) PT Lowered to $44 at Citi
-
Chemours (CC) PT Lowered to $61 at Citi
-
The Chemours Company Announces Early Tender Results of Conditional Cash Tender Offer and Consent Solicitation for Up to $250,000,000 of Its 6.625% Senior Notes Maturing In 2023
-
The Chemours Company Announces Early Tender Results of Conditional Cash Tender Offer and Consent Solicitation for Any and All of Its 6.125% Senior Notes Maturing in 2023 and Receipt of Requisite Conse
-
Chemours Announces Pricing Of Public Offering Of €450 Million Of 4.000% Senior Notes Due 2026
-
The Chemours Company Announces Conditional Cash Tender Offer And Consent Solicitation Of Up To $250,000,000 Of 6.625% Senior Notes Maturing In 2023
-
The Chemours Company Announces Conditional Cash Tender Offer And Consent Solicitation And Redemption Of 6.125% Senior Notes Maturing In 2023
-
Chemours Announces Commencement of Public Offering Of Senior Notes
-
Chemours (CC) PT Raised to $69 at Citi
-
Chemours (CC) PT Lowered to $66 at Citi
-
Chemours (CC) PT Raised to $68 at Citi
-
Chemours (CC) PT Raised to $59 at Citi
-
Citi Upgrades Chemours (CC) to Buy, Could Raises Dividend Or Buyback Shares
-
The Chemours Company Announces Completion of $500,000,000 of 5.375% Senior Notes Due 2027
-
The Chemours Company Announces Pricing of $500,000,000 of Senior Notes Due 2027
-
The Chemours Company Announces Offering of $500,000,000 of Senior Notes Due 2027
-
Chemours (CC) PT Raised to $40 at Citi
-
Chemours (CC) Investors May Underestimate Size of Liability - Bloomberg, Citing Citi
-
The Chemours Company's Paul Kirsch to Speak at Citi Basic Materials Conference
-
Notable Analyst Rating Changes 3/14: (CYBR) (TSLA) (RDC) Upgraded; (ALV) (KNX) (AG) Downgraded
-
The Chemours Company CEO Mark Vergnano to Speak at Citi Basic Materials Conference
-
Notable Analyst Rating Changes 8/14: (KMI) (CYBR) (DD) Upgraded; (KSS) (PLNR) (WEX) Downgraded
-
Citi Starts Chemours (CC) at Neutral
-
David Moenning's Daily State of the Markets: 10/23
-
Unusual 11 Mid-Day Movers 9/30: SOV, HUN, WB, NCC Higher; ALD, CC, RRI, HIG Lower
-
David Moenning's Daily State of the Markets: 9/23
-
Notable Analyst Rating Changes 8/5: AIG, CREE, WBD Upgraded; NT, FIG, RACK Downgraded
-
David Moenning's Daily State of the Markets: 06/19
-
Pre-Open Movers 6/19: Apria Healthcare (AHG) Up on Buyout, Huntsman (HUN) Sinks As Merger In Trouble
-
Citi Reiterates 'Buy' Rating on Blockbuster (BBI), Increases Price Target
-
Citi Maintains 'Buy' Rating on Blockbuster (BBI), Says Negative Sentiment Overdone
-
Notable Analyst Rating Changes 4/25: NOC, WMT, BIDU, KR Upgraded; F, RTN, MMM Downgraded
-
First Step or False Signal? Could Last Week’s Surge in Stocks Signal a Rebound Ahead?
-
Outlook 2008: Blockbuster is the Latest Blue Chip to Lead a Resurgence in M&A Deals
-
David Moenning's Daily State of the Markets: 4/9
-
Pre-Open Movers 4/9: Nektar (NKTR), MannKind (MNKD) Sink on Inhaled Insulin Worries; EP MedSystems (EPMD) Up on Buyout
-
Notable Analyst Rating Changes 1/25: HAL, SPWR, NOK, NYX Upgraded; T, RDS.A, CRA Downgraded